Tumor-derived exosomes remodel the ECM by accumulating fibronectin and promoting ECM-modifying enzyme lysyl oxidase (LOX) crosslinking to enhance the adhesion of the bone-marrow-derived cells which are essential pre-metastatic niche components [113,118,119]. The gene discussed is LOX; the disease is neoplasm.